| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11906-005-0081-5 |
| P698 | PubMed publication ID | 15748532 |
| P2093 | author name string | Mark E Cooper | |
| Karin A M Jandeleit-Dahm | |||
| Georgia Soldatos | |||
| P2860 | cites work | Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance | Q24617743 |
| Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 | Q27860575 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus | Q68065122 | ||
| Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle | Q71061241 | ||
| Risk factors for ischaemic heart disease: is it time to measure insulin? | Q71762080 | ||
| Effect of experimental potassium deficiency on glucose and insulin metabolism | Q72137255 | ||
| Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats | Q73015367 | ||
| Altered immunoreactivity of islet amyloid polypeptide (IAPP) may reflect major modifications of the IAPP molecule in amyloidogenesis | Q73556343 | ||
| Amylin and hypertension: the status of the current debate | Q73640761 | ||
| Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors | Q73783792 | ||
| Metformin reduces systemic methylglyoxal levels in type 2 diabetes | Q77804967 | ||
| Insulin increases angiotensinogen expression in human abdominal subcutaneous adipocytes | Q79293810 | ||
| Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta | Q28188643 | ||
| New Markers of Inflammation and Endothelial Cell Activation | Q28211342 | ||
| NAD(P)H oxidase: role in cardiovascular biology and disease | Q29616102 | ||
| Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity | Q29616103 | ||
| Protein glycation, diabetes, and aging | Q32120059 | ||
| Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes | Q33957444 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond | Q34282992 | ||
| The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm | Q34728204 | ||
| Adipose tissue as an endocrine organ: impact on insulin resistance. | Q35208997 | ||
| Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha | Q35209149 | ||
| Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring | Q35594333 | ||
| Protein glycation: a firm link to endothelial cell dysfunction | Q35857303 | ||
| Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle | Q37175187 | ||
| Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory | Q38289787 | ||
| Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats | Q39759463 | ||
| Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance | Q40934232 | ||
| Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide | Q41061275 | ||
| Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction | Q41144827 | ||
| Atherosclerosis and the two faces of endothelial nitric oxide synthase | Q41690339 | ||
| Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats | Q42452058 | ||
| Long-term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits B cell function | Q42528402 | ||
| Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity | Q42811622 | ||
| Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes | Q42826146 | ||
| Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells | Q43798535 | ||
| Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. | Q44043194 | ||
| Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms | Q44142905 | ||
| Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients | Q44185328 | ||
| Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy | Q44195281 | ||
| Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial | Q44396155 | ||
| Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control | Q44417109 | ||
| Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice | Q44453007 | ||
| Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism | Q44582556 | ||
| Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy | Q44609997 | ||
| Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. | Q44816727 | ||
| Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells | Q45028926 | ||
| Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study | Q46430157 | ||
| Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products | Q47231228 | ||
| Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. | Q51559659 | ||
| Role of islet amyloid polypeptide secretion in insulin-resistant humans. | Q52382138 | ||
| The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats. | Q52572402 | ||
| ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide. | Q54088174 | ||
| Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. | Q54338098 | ||
| Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. | Q54790389 | ||
| Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE | Q63433994 | ||
| P433 | issue | 2 | |
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 96-102 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Current Hypertension Reports | Q15746362 |
| P1476 | title | Advanced-glycation end products in insulin-resistant states | |
| P478 | volume | 7 |
| Q36915810 | Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food. |
| Q37093990 | Altered profile of circulating endothelial progenitor cells in obstructive sleep apnea. |
| Q40233829 | Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease? |
| Q26785504 | Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches |
| Q37042021 | Endothelial dysfunction: the early predictor of atherosclerosis. |
| Q64063180 | Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs |
| Q37789186 | Inflammation as death or life signal in diabetic fracture healing. |
| Q37120295 | Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction |
| Q39996387 | Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation |
Search more.